← 治験一覧に戻る
3T MRI CIEDの市販後調査
基本情報
- NCT ID
- NCT02969395
- ステータス
- 完了
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 41
- 治験依頼者名
- Medtronic
概要
The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).
対象疾患
Cardiac Rhythm Disorder
依頼者(Sponsor)
メドトロニック(INDUSTRY)